Welcome to IPRO's Management of Anticoagulation in the Peri-Procedural Period app.
Despite the considerable efficacy of antithrombotics and the increased number of oral anticoagulants now available, preventable bleeding and thrombotic events are still unacceptably common. While recently marketed agents require less laboratory monitoring, problems with the clinical management of anticoagulated patients persist, particularly in the peri-procedural period.
Surgery and invasive medical interventions increase the risk of bleeding, while withholding anticoagulants increases the risk of thrombosis due to the underlying condition(s) for which anticoagulation was originally prescribed. The clinical team must therefore balance these competing risks and make educated decisions regarding the decision to interrupt oral anticoagulation for a medical procedure and, if interrupted, whether to "bridge" anticoagulation with injectable anticoagulants, such as low molecular weight heparin (LMWH) in warfarin treated patients.
This guide, updated in 2016, is intended to:
This material was created in April 2014 by the multidisciplinary members of the Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, the Medicare Quality Improvement Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 10SOW-NY-AIM-7.3-14-01
Date of original webinar: May 12, 2017
Expiration date: May 11, 2018
The Medical Society of the State of New York designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Alex C Spyropoulos, MD, FACP, FCCP, FRCPC
Professor of Medicine, Hofstra Northwell School of Medicine Professor, The Merinoff Center for Patient-Oriented Research -The Feinstein Institute for Medical Research Director, Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital
Jessica Cohen, MD
Division of Hospital Medicine, North Shore University Hospital, Department of Medicine Assistant Professor of Medicine, Hofstra Northwell School of Medicine
Intended Audience: physicians, pharmacists, nurses, or any clinician responsible for anticoagulation management
How do you receive Continuing Medical Education credit for the enduring webinar?
The patient education materials below provide information for patients on managing their anticoagulation therapy before, during, and after planned or elective surgical or invasive procedures. These materials can be used for patient education and knowledge assessment in any healthcare setting and were produced in collaboration with The National Blood Clot Alliance.
Understanding anticoagulant risk prevention when surgery or other procedures are planned. - A patient’s guide to understanding their anticoagulation regimen may be altered due to a surgery or procedure. Additionally, the bottom of the form is for the patient to record their specific directions from the clinician.
Anticoagulation management: What to expect when surgery or other medical or dental procedures are planned. - A comprehensive description of anticoagulants and their use in patients, including before, during, and after procedures.
A quick reference of anticoagulation management, what to expect when surgery or other medical or dental procedures are planned. – A one page summary of the above comprehensive description.
Patient knowledge assessment. - After reading the educational materials about anticoagulation management when surgery or invasive procedures are planned, test your knowledge by answering the questions below. Share the results with your doctor or other healthcare provider.
For more patient centered information about blood clots:
The National Blood Clot Alliance
A non-profit, patient-led, voluntary health organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots.Stop The Clot
IPRO is a national organization providing a full spectrum of healthcare assessment and improvement services that foster more efficient use of resources and enhance healthcare quality to achieve better patient outcomes. Founded in 1984, IPRO is highly regarded for the independence of its approach, the depth of its knowledge and experience, and the integrity of its programs. IPRO holds contracts with federal, state and local government agencies, as well as private-sector clients, in more than 33 states and the District of Columbia. A national not-for-profit organization, IPRO is headquartered in Lake Success, NY and also has offices in Albany, NY, Hamden, CT, Camp Hill, PA, Morrisville, NC, Princeton, NJ, San Francisco, CA.
IPRO’s staff of more than 400 professionals includes physicians, registered nurses, mental health professionals, epidemiologists, biostatisticians, data analysts, medical record reviewers, health policy experts, pharmacists, coding professionals, claims analysts, auditors, programmers, systems analysts, web technology experts and healthcare communications specialists. IPRO also retains a network of more than 300 board-certified physician consultants.